Search

everythinglearnresearchcommunity

for

Search:↓

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Acne significantly affects both physical health and mental well-being.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Combining Traditional Chinese Medicine and Western medicine can improve symptoms, hormone levels, and pregnancy outcomes in Polycystic Ovary Syndrome patients, but more research is needed.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.